ASX:AYAHealthcare Services
Assessing Artrya (ASX:AYA)’s Valuation After Its New Three-Year U.S. Hospital Agreement
Artrya (ASX:AYA) has secured a three year commercial agreement to deploy its Salix platform across Northeast Georgia Health System, providing at least A$300,000 in revenue with additional potential from per scan fees.
See our latest analysis for Artrya.
The announcement appears to have accelerated an already powerful trend, with a 7 day share price return of 25.56 percent contributing to a 533.87 percent year to date share price return and a 727.37 percent 1 year total shareholder return...